Skip to main content
TipRanks
Go Ultimate75% OFF

Bertil Lindmark Insider Profile

4 Followers

Bertil Lindmark, CMO at Damora Therapeutics, holds 16.60K shares in Damora Therapeutics (Ticker: DMRA). Most recently, Bertil Lindmark Bought 14,604 shares of Damora Therapeutics on Mar 23, 2022 for an estimated value of $31.54K.

Bertil Lindmark's Trading History

DMRA
Damora Therapeutics
Mar 23, 2022CMOInformative Buy31.54K$358.65K
DMRA
Insider Shares: 16.60K (0.00%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Mar 23, 2022Informative Buy$31.54K14,604$2.16-20.00%
Jun 28, 2021Informative Buy$10.52K2,000$5.26-66.70%

You May Also Like

Bertil Lindmark insider profile FAQ

What is the percentage of profitable transactions made by Bertil Lindmark?
The percentage of profitable transactions made by Bertil Lindmark is 0%.
What is the average return per transaction made by Bertil Lindmark?
The average return per transaction made by Bertil Lindmark is -43.30%.
What stocks does Bertil Lindmark hold?
Bertil Lindmark holds: DMRA stocks.
What was Bertil Lindmark’s latest transaction?
Bertil Lindmark’s latest transaction was an Informative Buy of $31.54K.
What was Bertil Lindmark's most profitable transaction?
Bertil Lindmark’s most profitable transaction was an Informative Buy of DMRA stock on March 23, 2022. The return on the trade was -20.00%.
What is Bertil Lindmark's role in Damora Therapeutics?
Bertil Lindmark's role in Damora Therapeutics is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.